Max F. Madu

Max F. Madu

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.

Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.

Journal: Nature communications
Published: February 07, 2023

Near-Infrared Fluorescence with Indocyanine Green to Assess Bone Perfusion: A Systematic Review.

Near-Infrared Fluorescence with Indocyanine Green to Assess Bone Perfusion: A Systematic Review.

Journal: Life (Basel, Switzerland)
Published: December 30, 2021

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.

Journal: Nature communications
Published: November 19, 2019

External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?

External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?

Journal: Melanoma research
Published: October 26, 2019

Challenges in sentinel node pathology in the era of adjuvant treatment.

Challenges in sentinel node pathology in the era of adjuvant treatment.

Journal: Journal of surgical oncology
Published: September 21, 2019

Reply to: Letter re: Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma: A multicenter experience.

Reply to: Letter re: Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma: A multicenter experience.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: February 14, 2019

Parotidectomy in patients with head and neck cutaneous melanoma with cervical lymph node involvement.

Parotidectomy in patients with head and neck cutaneous melanoma with cervical lymph node involvement.

Journal: Head & neck
Published: August 14, 2018

Comment: Detailed Pathologic Examination of Completion Node Dissection Specimens and Outcome for Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases.

Comment: Detailed Pathologic Examination of Completion Node Dissection Specimens and Outcome for Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases.

Journal: Annals of surgical oncology
Published: October 17, 2017

Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria.

Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria.

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 29, 2017

PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study.

PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study.

Journal: Melanoma research
Published: February 23, 2017

Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin.

Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin.

Journal: The British journal of surgery
Published: February 07, 2017

Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience.

Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 23, 2017
Showing 1-12 of 19

Last Updated: 09/26/2026